Parameters | Training set (n = 184) | Validation set (n = 80) | ||||
---|---|---|---|---|---|---|
MSI-H (n = 51) | MSI-L/MSS (n = 133) | p value* | MSI-H (n = 51) | MSI-L/MSS (n = 133) | p value* | |
Arterial phase | ||||||
 CT40keV_AP, HU | 120.07 (95.50, 150.99) | 126.87 (109.36, 150.24) | 0.290 | 115.49 (87.77, 152.19) | 120.01 (86.74, 150.50) | 0.950 |
 CT70keV_AP, HU | 65.98 (55.98, 76.40) | 66.19 (59.07, 78.82) | 0.698 | 63.43 (55.15, 74.65) | 64.24 (51.33, 76.52) | 0.968 |
 IDAP, mg/ml | 0.96 (0.70, 1.32) | 0.99 (0.79, 1.42) | 0.287 | 0.87 (0.74, 1.17) | 0.91 (0.64, 1.27) | 0.928 |
 NIDAP | 0.10 (0.08, 0.14) | 0.11 (0.08, 0.16) | 0.517 | 0.09 (0.06, 0.11) | 0.10 (0.08, 0.13) | 0.173 |
 ZeffAP | 7.81 (7.67, 7.90) | 7.83 (7.69, 8.03) | 0.394 | 7.80 (7.65, 7.95) | 7.80 (7.65, 8.03) | 0.991 |
 λHUVP | 1.37 (1.02, 1.55) | 1.39 (1.06, 2.02) | 0.340 | 1.21 (0.68, 1.42) | 1.25 (0.85, 1.82) | 0.494 |
Venous phase | ||||||
 CT40keV_VP, HU | 145.38 (124.25, 193.55) | 167.37 (145.80, 198.73) | 0.012 | 144.96 (130.04, 173.92) | 177.77 (150.14, 197.73) | 0.006 |
 CT70keV_VP, HU | 79.20 (69.59, 90.48) | 85.70 (73.49, 97.48) | 0.035 | 73.82 (66.78, 85.00) | 84.60 (74.21, 98.86) | 0.026 |
 ID VP, mg/ml | 1.11 (0.98, 1.42) | 1.52 (1.34, 1.87) |  < 0.001 | 1.21 (0.98, 1.38) | 1.56 (1.39, 1.99) |  < 0.001 |
 NIDVP | 0.26 (0.20, 0.29) | 0.34 (0.28, 0.41) |  < 0.001 | 0.23 (0.18, 0.29) | 0.34 (0.28, 0.40) |  < 0.001 |
 ZeffVP | 7.87 (7.81, 7.99) | 8.13 (8.05, 8.27) |  < 0.001 | 7.83 (7.75, 7.95) | 8.15 (8.07, 8.35) |  < 0.001 |
 λHUVP | 1.31 (0.90, 1.81) | 2.19 (1.78, 2.92) |  < 0.001 | 1.50 (1.18, 2.98) | 2.30 (1.82, 2.97) | 0.002 |